And I think some investors are very, you know, kind of tempted by the valuation disconnect between Lily and Novo, but we're still on the sidelines as we think the fundamentals for Lily are stronger than Novo at this point in time
Providers increasingly encounter patients Read More Protecting Muscle While Treating Obesity: New Protein Targets for Older Adults on GLP-1s Jun 16, 2026 Articles, Diet and Nutrition, Exercise, Geriatric Medicine, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity 1,660 views The rise of highly effective GLP-1 receptor agonists and dual incretin therapies has transformed obesity treatment
Glucagon-like peptide-1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study
V.StruweW
Researchers have studied carnosine in its various forms for decades
NativePath's co-founder, Dr